Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details) - Supplier Concentration Risk - Vendor One
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Research and development expenditures          
Concentration          
Concentration Risk (as a percent) 66.00% 52.00% 50.00% 45.00%  
Accounts payable and accrued expense          
Concentration          
Concentration Risk (as a percent)     55.00%   5.00%